These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2862846)

  • 1. [Therapeutic possibilities of nicergoline in neurogenic bladder dysfunction].
    Gallego Gómez J; Jiménez Cruz JF; Martínez Agulló E; Mompó Sanchís JA; Llopis Mínguez B; Boronat Tormo F
    Arch Esp Urol; 1985; 38(2):175-90. PubMed ID: 2862846
    [No Abstract]   [Full Text] [Related]  

  • 2. Nicergoline in the treatment of neuropathic bladder dysfunction: a preliminary report.
    Gallego J; Forner V; Jimenez F; Martinez E
    Paraplegia; 1984 Aug; 22(4):216-24. PubMed ID: 6483464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alpha adrenergic blocking agents in disorders of the bladder sphincter].
    Perrigot M; Vannier A; Bor Y
    Rev Prat; 1986 Jan; 36(5):223-8. PubMed ID: 2421393
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relaxing effect of nicergoline on the female urethra in peripheral neurogenic vesicosphincter dysfunctions].
    Galas JM; Grillot MJ; Vasse MG; Vaillandet M; Guillemin P
    J Urol (Paris); 1984; 90(8-9):563-5. PubMed ID: 6398829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy of subureteral collagen injection for endoscopic treatment of vesicoureteral reflux in neurogenic bladder cases.
    Haferkamp A; Möhring K; Staehler G; Gerner HJ; Dörsam J
    J Urol; 2000 Jan; 163(1):274-7. PubMed ID: 10604375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of injectable sermion in otologic diseases].
    Gaillard J; Dubreuil C
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1979 Sep; 28(7):477-80. PubMed ID: 41025
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and urodynamic assessment of alpha-adrenolytic therapy in patients with neurogenic bladder function.
    Hachen HJ
    Paraplegia; 1980 Aug; 18(4):229-40. PubMed ID: 6106920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short-term and long-term results of treatment of chronic arteriopathies of the lower limbs with nicergoline. Importance of intensive medical therapy].
    Quiroli A
    Minerva Cardioangiol; 1980 Dec; 28(12):793-804. PubMed ID: 6111767
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vesico-ureteral reflux in patients with neurogenic bladder dysfunction: causes, types, treatment, development and results].
    Rodó Salas J; Costa JM; Escolá J
    An Esp Pediatr; 1987 Oct; 27(4):284-6. PubMed ID: 3426021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of alpha-1 adrenergic innervation of the urinary bladder in human neurogenic vesical dysfunction.
    Vaidyanathan S; Rao MS; Sharma PL; Sachdeva NK
    Indian J Med Res; 1983 Apr; 77():529-33. PubMed ID: 6135662
    [No Abstract]   [Full Text] [Related]  

  • 11. Improvement of urethral resistance after the administration of an alpha-adrenoceptor blocking agent, urapidil, for neuropathic voiding dysfunction.
    Yamanishi T; Yasuda K; Tojo M; Hattori T; Sakakibara R; Shimazaki J
    Paraplegia; 1994 Apr; 32(4):271-6. PubMed ID: 7912822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservative management of vesicoureteric reflux in the congenital neurogenic bladder.
    Philp NH; Rickwood AM; Thomas DG
    Br J Urol; 1981 Dec; 53(6):545-51. PubMed ID: 7317740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urodynamic study of lower urinary tract. V. Alpha adrenergic blocker for the treatment of neurogenic bladder dysfunction (author's transl)].
    Kondo A; Otani T; Kobayashi M; Narita H; Takita T
    Nihon Hinyokika Gakkai Zasshi; 1978 Aug; 69(8):988-99. PubMed ID: 713212
    [No Abstract]   [Full Text] [Related]  

  • 14. [Urodynamic study of the neurogenic bladder. IV. Radiologic-urodynamic correlation].
    Gallego Gómez J; Jiménez Cruz JF; Martínez Agulló E; Mompó Sanchís JA; Boronat Tormo F; Martínez García R
    Arch Esp Urol; 1984; 37(5):425-36. PubMed ID: 6517628
    [No Abstract]   [Full Text] [Related]  

  • 15. Urodynamic examination of the lower urinary tract in children with normal and congenital neurogenic bladder.
    Thorup J
    Scand J Urol Nephrol Suppl; 1994; 158():1-59. PubMed ID: 7817158
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha-adrenolytic treatment of the congenital neuropathic bladder.
    Stockamp K; Schreiter F
    Urol Int; 1975; 30(1):33. PubMed ID: 235166
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical effect of new alpha-adrenergic blocker on micturition disturbance of neurogenic bladder and lower urinary tract obstruction].
    Takimoto Y; Kitamura K; Fuse T; Kawazoe K; Hirano D; Amagai T; Kiyotaki S
    Hinyokika Kiyo; 1983 Feb; 29(2):255-63. PubMed ID: 6145342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alpha-blockers and treatment of coronary artery vasospasm].
    Weber S; Chapsal J; Pipeau C; Degeorges M
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():131-6. PubMed ID: 6134505
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of the efficacy of an alpha-I-adrenergic blocker in the slow calcium channel blocker in the control of autonomic dysreflexia.
    Lindan R; Leffler EJ; Kedia KR
    Paraplegia; 1985 Feb; 23(1):34-8. PubMed ID: 2858840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trigonal injection of botulinum toxin-A does not cause vesicoureteral reflux in neurogenic patients.
    Mascarenhas F; Cocuzza M; Gomes CM; Leão N
    Neurourol Urodyn; 2008; 27(4):311-4. PubMed ID: 17914742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.